טוען...
Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish
Glucagon antagonism is a potential treatment for diabetes. One potential side effect is α-cell hyperplasia, which has been noted in several approaches to antagonize glucagon action. To investigate the molecular mechanism of the α-cell hyperplasia and to identify the responsible factor, we created a...
שמור ב:
| הוצא לאור ב: | J Endocrinol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598637/ https://ncbi.nlm.nih.gov/pubmed/26446275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JOE-15-0284 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|